Update on lupus nephritis

被引:0
作者
Schneider, M. [1 ,2 ,4 ]
Schwarting, A. [3 ]
Chehab, G. [1 ,2 ]
机构
[1] Heinrich Heine Univ Dusseldorf, Klin Rheumatol, UKD, Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Hiller Forschungszentrum Rheumatol, UKD, Moorenstr 5, D-40225 Dusseldorf, Germany
[3] Johannes Gutenberg Univ Mainz, Univ Med, Rheumatol & Klin Immunol, Mainz, Germany
[4] Heinrich Heine Univ Dusseldorf, Klin Rheumatol, UKD, Moorenstr 5, D-40225 Dusseldorf, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2024年 / 83卷 / 06期
关键词
Lupus nephritis; Systemic lupus erythematosus; Treatment; Prognosis; DISEASE; ERYTHEMATOSUS; MANAGEMENT; REMISSION; DAMAGE;
D O I
10.1007/s00393-024-01534-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In addition to the butterfly rash, lupus nephritis is the most specific manifestation of systemic lupus erythematosus (SLE). The perspective on this organ manifestation has fundamentally changed as well as the manifestation of SLE itself 40 years after the first multicenter clinical study on lupus nephritis. Even if there is a faint glimpse of hope of a cure, there is still the fight against the problem of nonresponders and also the progressive loss of organ function. This update gives an overview of the current importance of lupus nephritis in the context of the whole SLE disease, of the special features and on the options provided by the new diagnostic and therapeutic developments.
引用
收藏
页码:447 / 454
页数:8
相关论文
共 61 条
[21]   Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis [J].
Furie, Richard ;
Rovin, Brad H. ;
Houssiau, Frederic ;
Malvar, Ana ;
Teng, Y. K. Onno ;
Contreras, Gabriel ;
Amoura, Zahir ;
Yu, Xueqing ;
Mok, Chi-Chiu ;
Santiago, Mittermayer B. ;
Saxena, Amit ;
Green, Yulia ;
Ji, Beulah ;
Kleoudis, Christi ;
Burriss, Susan W. ;
Barnett, Carly ;
Roth, David A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12) :1117-1128
[22]   B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial [J].
Furie, Richard A. ;
Aroca, Gustavo ;
Cascino, Matthew D. ;
Garg, Jay P. ;
Rovin, Brad H. ;
Alvarez, Analia ;
Fragoso-Loyo, Hilda ;
Zuta-Santillan, Elizabeth ;
Schindler, Thomas ;
Brunetta, Paul ;
Looney, Cary M. ;
Hassan, Imran ;
Malvar, Ana .
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (01) :100-107
[23]   KDIGO 2024 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS [J].
Grams, Morgan E. ;
Jadoul, Michel .
KIDNEY INTERNATIONAL, 2024, 105 (01) :S1-S69
[24]   Dapagliflozin in Patients with Chronic Kidney Disease [J].
Heerspink, Hiddo J. L. ;
Stefansson, Bergur V. ;
Correa-Rotter, Ricardo ;
Chertow, Glenn M. ;
Greene, Tom ;
Hou, Fan-Fan ;
Mann, Johannes F. E. ;
McMurray, John J. V. ;
Lindberg, Magnus ;
Rossing, Peter ;
Sjostrom, C. David ;
Toto, Roberto D. ;
Langkilde, Anna-Maria ;
Wheeler, David C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (15) :1436-1446
[25]  
Horisberger Alice, 2024, bioRxiv, DOI 10.1101/2024.01.14.575609
[26]   Deciphering the Genetic Code of Autoimmune Kidney Diseases [J].
Huang, Stephanie U-Shane ;
Kulatunge, Oneli ;
O'Sullivan, Kim Maree .
GENES, 2023, 14 (05)
[27]   Anti--enolase antibody combined with 2 microglobulin evaluated the incidence of nephritis in systemic lupus erythematosus patients [J].
Huang, Y. ;
Chen, L. ;
Chen, K. ;
Huang, F. ;
Feng, Y. ;
Xu, Z. ;
Wang, W. .
LUPUS, 2019, 28 (03) :365-370
[28]   Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis [J].
Jamaly, Simin ;
Rakaee, Mehrdad ;
Abdi, Reza ;
Tsokos, George C. ;
Fenton, Kristin Andreassen .
AUTOIMMUNITY REVIEWS, 2021, 20 (12)
[29]   Severe lupus nephritis: the predictive value of a ≥50% reduction in proteinuria at 6 months [J].
Korbet, Stephen M. ;
Lewis, Edmund J. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (09) :2313-2318
[30]   New insights into the role of renal resident cells in the pathogenesis of lupus nephritis [J].
Kwok, Seung-Ki ;
Tsokos, George C. .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2018, 33 (02) :284-289